Drug Discovery & Pharmaceuticals

RSS

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Quanterix announce agreement to acquire privately held UmanDiagnostics AB for $22.5 million.

From Quanterix 26 Jun 2019

Using Light Scattering to Characterize Protein-Nucleic Acid Interactions

Harnessing the interactions between DNA, RNA, and proteins holds much promise for detecting biomarkers, diagnosing disease, and improving cancer-targeting therapeutics. Quantifying these interactions is essential for understanding and controlling their biomolecular mechanisms.

From Waters | Wyatt Technology 26 Jun 2019

Cannabis ingredient shows promise as potential antibiotic for superbugs

Researches at the University of Queensland in Australia have discovered that a topical formulation containing cannabidiol (CBD) is effective at killing bacterial skin infections.

25 Jun 2019

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

In this interview, Prof. Elborn and Dr. Dixon discuss the issues involving chronic lung conditions such as cystic fibrosis and bacterial respiratory infections.

From Neem Biotech 25 Jun 2019

Atomwise and Enamine launch 10 billion compound virtual drug screening initiative

Atomwise, Inc. today announced the launch of a 10 billion compound AI-powered virtual drug screening initiative, the 10-to-the-10 program, in collaboration with Enamine Ltd., the world’s largest chemical supplier.

25 Jun 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

Nanion launches HTS automated patch clamp platform

The SyncroPatch 384i is a giga-ohm seal HTS automated patch clamp platform designed for flexibility, ease-of-use and reliability.

From Nanion Technologies 25 Jun 2019

Highlights and key takeaways from the 2019 Boston Bacterial Meeting (BBM)

Missed out on the 2019 Boston Bacterial Meeting (BBM)? Read our round-up of the key takeaways, areas of discussion, speakers and more.

19 Jun 2019

Creating a physical and genetic map of Cannabis sativa

Scientists have developed a physical and genetic map of Cannabis sativa to facilitate further investigation into the genetic and molecular mechanisms exhibited by this plant.

19 Jun 2019

Metabolic engineering of cannabinoids – are we there yet?

There has recently been a surge in research into the biosynthetic pathways of cannabinoids and the potential for commercialized metabolic engineering.

19 Jun 2019

Harnessing the power of skin microbiome to develop new therapeutics

As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic, dermatological & cosmetic researchers, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics).

From The Microbiome Movement 19 Jun 2019

Invitation to attend Microbiome Movement – Drug Development & Nutrition Summit in Singapore

As the Program Director of the Microbiome Movement, I would like to formally invite you to join us an esteemed member of the delegation for the inaugural Microbiome Movement – Drug Development & Nutrition Summit taking place September 17-18 in Singapore.

From The Microbiome Movement 19 Jun 2019